Dan Ramirez
@fdanielramirez
Followers
269
Following
1K
Media
0
Statuses
243
Cardiac EP, Clinician-Scientist | Alum: @uOttawaScience @QueensUHealth @OttawaIM @HeartInstitute @uOttawa_SEPH @CHUBordeaux
Joined May 2017
📖 A new comprehensive protocol for recurrent paroxysmal atrial fibrillation (PAF) ablation resulted in arrhythmia-free survival at 1-year in 53% of patients. None of the ablation protocol’s steps were suggested to independently improve procedural success ⬇️
0
6
11
Sharing what we hope is an important paper in #SHOCK out today in @NEJMEvidence by @JungRichardG (who just matched to cardiology!). Prognostic Factors Associated with Mortality in Cardiogenic Shock — A Systematic Review and Meta-Analysis | NEJM Evidence
evidence.nejm.org
Cardiogenic shock remains highly associated with early mortality, with mortality often exceeding 50%. We sought to determine the association between prognostic factors and in-hospital and 30-day mo...
3
50
135
We clearly need more dedicated #CICU trials of #VTstorm to learn how to treat these patients. It's like early days of cardiogenic shock. With @fdanielramirez we are doing the SEDATE trial looking at Precedex up front for treatment of VT storm and have started recruiting.
2
8
22
#VTstorm is a common problem in #CICU #critcarecardio. SGB is purported to be a treatment for this condition. @_profmota reports in @SciReports @NaturePortfolio an overview of data supporting this strategy. https://t.co/FGvvznOFe5 for the open access PDF
3
8
41
🚨New #FreeRead Article in @JICE_EP Optimized Workflow for PVI using 90-W Radiofrequency Applications: a Comparative Study by @AgustinBortone @fdanielramirez S Combes, G Laborie, JP Albenque, FA Sebag & LR Limite 🧐📖 https://t.co/G9fDPrRrx6
#EPeeps
1
15
37
Optimized workflow for pulmonary vein isolation using 90-W radiofrequency applications: a comparative study.
pubmed.ncbi.nlm.nih.gov
In paroxysmal AF patients, a combined (90-50 W) strategy for PVI did not improve safety, efficiency, or effectiveness compared to a 50 W-only AI-guided strategy.
0
3
4
Clinically relevant arrhythmic events occur in approximately half of patients with #CardiogenicShock treated with dobutamine or milrinone and are associated with adverse clinical outcomes #cardiotwitter #CJC 👉 https://t.co/7M00bYyTXR
0
2
5
High-resolution mapping of reentrant atrial tachycardias: relevance of low bipolar voltage @fdanielramirez
https://t.co/pjnnfiwTJX
0
6
19
High-resolution mapping of reentrant atrial tachycardias: relevance of low bipolar voltage, by @fdanielramirez and colleagues
2
3
7
Can #smartwatch #ECG be used in children? #epeeps from @ihu_liryc @CHUBordeaux show how @Apple ⌚️ ECGs recorded with parental assistance (<6y 👩👦) and independently (>6y🧒) can detect🫀conditions. In Journal of Pediatrics with temporary free access here: https://t.co/WbFhjg4nGx
1
12
24
Newest DOREMI substudy from @benhibbertMDPhD's lab in @CJCJournals 🚨 - led by @fdanielramirez where we reveal 48% in those with cardiogenic shock had arrhythmic events while on inotropes with increased odds of mortality. #Cardio
https://t.co/4FtzR4AiEG
0
12
27
Our latest from the @benhibbertMDPhD lab, published in @Open_HeartBMJ. AF is highly predictive of adverse outcomes following coronary revascularization. AF is a stronger predictor of MACE than traditional risk factors ie T2DM/reduced LVEF in this study. https://t.co/Czc1LEpZQt
2
8
30
Latest publication alert 🚨 from @benhibbertMDPhD's lab at @JACCJournals - we demonstrate that PAI-1 extracellular vesicles are biomarkers for MACE in CAD. Also, PAI-1 EV modulates the proinflammatory vascular SMC phenotype opening a target for ISR. https://t.co/mWwy2Xx5JA
3
16
43
Female Representation in Clinical Studies Informing #AF Guidelines: Have We Built a House of Cards? 👉 https://t.co/cOvBC4DRtX
@fdanielramirez @thaiscoutinhoCV @HeartInstitute @CWHHAlliance #CJC
0
2
11
Noncontact whole-chamber charge density mapping of the left ventricle: Preclinical evaluation in a sheep model, by @fdanielramirez @JRWinterfield @PierreJais et al
0
3
11
Even @McLarenF1 #F1 wanted to congratulate you @JungRichardG. Simply outstanding PhD and excited about all the work to come. @danielricciardo @LandoNorris
We are pleased to announce Dr. Richard Jung is the 2022 Ottawa Cardiovascular Research Trainee of the Year! @JungRichardG is recognized for his exceptional productivity in research and outstanding leadership in the community. 👀Read more: https://t.co/Gw3CbrPoQr
2
4
23
Great work led by @AgustinBortone (now on Twitter). Thankful for the opportunity to be involved
90 vs 50-Watt Radiofrequency Applications for Pulmonary Vein Isolation: Experimental and Clinical Findings @fdanielramirez @EloiMarijon #AHAJournals #Epeeps
https://t.co/OL5KORh1fh
0
0
1
Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients with Heart Failure and Atrial Fibrillation: results from the RAFT-AF trial https://t.co/6USscnP9Vi
@AnthonyTang6 @EPjeff17 @CHRS_SCR @CANetChat
ahajournals.org
Background: Atrial fibrillation (AF) and heart failure (HF) frequently coexist and can be challenging to treat. Pharmacologically based rhythm control of AF has not proven to be superior to rate...
0
13
33
ICYMI: @fdanielramirez spoke "Fluoroscopic Landmarks and Transseptal Puncture" at our @CHRS_SCR webinar last Friday! https://t.co/TriGplbJdt
@OttawaHeartEP @uOttawa @MouhannadSadek And check out our other webinars:
0
5
7